Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050

Reuben Granich, James G Kahn, Rod Bennett, Charles B Holmes, Navneet Garg, Celicia Serenata, Miriam Lewis Sabin, Carla Makhlouf-Obermeyer, Christina De Filippo Mack, Phoebe Williams, Louisa Jones, Caoimhe Smyth, Kerry A Kutch, Lo Ying-Ru, Marco Vitoria, Yves Souteyrand, Siobhan Crowley, Eline L Korenromp and Brian G Williams

PLOS ONE, 2012, vol. 7, issue 2, 1-15

Abstract: Background: Antiretroviral Treatment (ART) significantly reduces HIV transmission. We conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa. Methods: We model a best case scenario of 90% annual HIV testing coverage in adults 15–49 years old and four ART eligibility scenarios: CD4 count

Date: 2012
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0030216 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 30216&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0030216

DOI: 10.1371/journal.pone.0030216

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().